New European Monographs Set ‘Robust Standards’ For Biosimilar Development
Executive Summary
A European Pharmacopoeia pilot project has resulted in the establishment of monographs for a number of complex biotherapeutics that will set “robust” standards for the development of biosimilars in the future.